Form 8-K Chemours Co For: Nov 28

Go back to Form 8-K Chemours Co For: Nov 28

Chemours (CC) lifted at RBC Capital on TiO2 margin recovery

December 1, 2023 11:18 AM EST

RBC Capital upgraded shares of Chemours (NYSE: CC) to Outperform from Sector Perform in a note Friday, raising the price target on the stock to $40 from $28 per share.

Analyst Arun Viswanathan said the firm is upgrading the stock based on the TiO2... More